MALAT1 and HOTAIR showed significant fluctuation in their expression under various cancer types, influencing inflammation, autophagy, migration, metastasis and therapeutic sensitisation, highlighting their potential for acting as a biomarker and therapeutic candidate (Goyal et al., 2021; Raju et al., 2023; Xin et al., 2021). The gene discussed is MALAT1; the disease is cancer.